سعر سيلجون 10مجم 6 اقماع لبوس رضع 2024

Antitussive suppositories for infants containing pipazethate 10 mg (EIPICO).

• Seizures, particularly with overdose (EDA safety signal).General active-ingredient information · Egyptian Drug Authority (EDA), Pharmaceutical Vigilance General Administration

• Egyptian Drug Authority safety signal: seizures associated with pipazetate, mostly after overdose (71% of cases), with most cases in children aged 6 months to 3 years; onset 25 minutes to 1 hour after administration. Different formulation concentrations can lead to medication errors.General active-ingredient information · Egyptian Drug Authority (EDA), Pharmaceutical Vigilance General Administration
• Egyptian Drug Authority regulatory measure: use of pipazetate is restricted in patients under 4 years of age, and product leaflets are to be updated to emphasise the risk of seizures with overdose.General active-ingredient information · Egyptian Drug Authority (EDA), Pharmaceutical Vigilance General Administration

• Pipazethate (pipazetate): Centrally acting antitussive acting on the medullary cough centre; also has local anaesthetic activity and binds the sigma-1 receptor; large doses can cause seizures.